Clinical Trials Browser

Anus Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

NCT03157856 2019-01-15

Bio-Prost

Terminated

8 enrolled

Genitourinary

Prostatic Neoplasms

NCT02694380 2018-08-09

Measuring the Effect of Radiation Therapy on Patient Activity Levels

Terminated

32 enrolled

BreastGenitourinaryHead & NeckThoracic

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT02250313 2018-07-26

PASCUAL

Terminated

600 enrolled

Genitourinary

Prostatic Neoplasms

NCT03073473 2018-07-20

Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers

Terminated

40 enrolled

BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Pancreatic Neoplasms, Prostatic Neoplasms

NCT01987193 2018-05-29

Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)

Terminated

3 enrolled

CNSGenitourinaryThoracic

Brain Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT01859338 2018-03-07

Soft Tissue Detection on MRI, Cone Beam CT and Fan Beam CT and Integration of Functional MRI

Terminated

26 enrolled

GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

NCT00447616 2017-12-26

Prostatectomy Prospective Database

Terminated

896 enrolled

Genitourinary

Prostatic Neoplasms

NCT02131207 2017-12-21

MRI Before Biopsy in Diagnosing Patients With Prostate Cancer

Terminated

139 enrolled

Genitourinary

Prostatic Neoplasms

NCT02454595 2017-09-05

Registry to Measure the Impact of Adding Genomic Testing

Terminated

116 enrolled

Genitourinary

Prostatic Neoplasms

NCT00898833 2017-08-08

Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583

Terminated

868 enrolled

Genitourinary

Prostatic Neoplasms

NCT02370355 2017-04-17

Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer

Terminated

24 enrolled

Genitourinary

Prostatic Neoplasms

NCT00823771 2017-02-02

PROFUGO

Terminated

107 enrolled

Genitourinary

Prostatic Neoplasms

NCT01832831 2016-04-21

Anatomical and Functional Differences Between Continent and Incontinent Men Post Radical Prostatectomy

Terminated

24 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

uPARCRPC

DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine

GENTleMEN

Collection of Blood in Studying Metabolites in Patients With Prostate Cancer

Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations

Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy

Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors

Genetic Evaluation of Men (GEM)

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

ES-HIFU

PSMA-PET/CT Registry

pCHIP: Prostate Cancer Health Impact Program

Immune PDX

Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy

PET-PSMA

Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy

CHARTER

In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies

An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital

Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer

Transrectal Photoacoustic Imaging of the Prostate

P-PROVE

ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting

Glycosylation of Exosomes in Prostate and Urothelial Carcinoma

Adaptation of an eHealth (Web-application) Platform for Delivery of a Sedentary Behavior Intervention Among Prostate Cancer Patients

Post-marketing Surveillance Regarding Efficacy and Safety of SpaceOAR™

Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy

Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate

Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients

Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study

Circulating Tumor Cells in Prostate Cancer Patients

PROUD

Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate Cancer

Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA Levels

PRIME

Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis

N1

Bio-Prost

Measuring the Effect of Radiation Therapy on Patient Activity Levels

PASCUAL

Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers

Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)

Soft Tissue Detection on MRI, Cone Beam CT and Fan Beam CT and Integration of Functional MRI

Prostatectomy Prospective Database

MRI Before Biopsy in Diagnosing Patients With Prostate Cancer

Registry to Measure the Impact of Adding Genomic Testing

Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583

Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer

PROFUGO

Anatomical and Functional Differences Between Continent and Incontinent Men Post Radical Prostatectomy